Question 1

What does it mean to monitor drug levels during treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Drug Concentration Monitoring of Pembrolizumab in Non-Small Cell Lung Cancer Patients clinical trial (NCT04557007). Contact the study team or your healthcare provider for specific answers.

Question 2

How might my treatment plan change based on the findings from this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Drug Concentration Monitoring of Pembrolizumab in Non-Small Cell Lung Cancer Patients clinical trial (NCT04557007). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential benefits of participating in this observational study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Drug Concentration Monitoring of Pembrolizumab in Non-Small Cell Lung Cancer Patients clinical trial (NCT04557007). Contact the study team or your healthcare provider for specific answers.

Question 4

Are there any risks or side effects related to monitoring drug levels?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Drug Concentration Monitoring of Pembrolizumab in Non-Small Cell Lung Cancer Patients clinical trial (NCT04557007). Contact the study team or your healthcare provider for specific answers.

Question 5

How will my participation affect my overall treatment schedule?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Drug Concentration Monitoring of Pembrolizumab in Non-Small Cell Lung Cancer Patients clinical trial (NCT04557007). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I don't qualify for this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Drug Concentration Monitoring of Pembrolizumab in Non-Small Cell Lung Cancer Patients clinical trial (NCT04557007). Contact the study team or your healthcare provider for specific answers.

What this study is about